This is a limited company view. Sign up for a Free Trial to see everything.

Ophthotech Is Developing Novel Therapies for Age-Related Macular Degeneration (AMD)

B2B
Biotechnology
Healthcare
Pharmaceuticals

Overview

Location

New York

Founded

Employees

28

Stage

Public

Total funding

$205M

Last funding

5 years ago

Acquisitions

0

Growth score

63

Mindshare score

68

Scoring

Deals

$50.0M Private Equity

Novo A/S

May 29, 2013

$125.0M Private Equity

Novo A/S

May 25, 2013

Other Investors

Sofinnova Ventures

Employee Growth

Use Ophthotech's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Ophthotech's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial

Key People

Chief Executive Officer (Executive Chairman
Chief Financial Officer
Chief Clinical Operations Officer
Senior Vice President
Senior Vice President
Senior Vice President and Chief Operating Officer
Senior Vice President and General Counsel

Similar Companies

Kodiak Sciences

Kodiak Sciences is a biopharmaceutical company designing and developing novel therapies for the treatment of retinal disease.
Series B|22 employees

Gain context with Mattermark Salesforce Enrichment

Find out how

Notes